JP2014516027A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014516027A5 JP2014516027A5 JP2014509823A JP2014509823A JP2014516027A5 JP 2014516027 A5 JP2014516027 A5 JP 2014516027A5 JP 2014509823 A JP2014509823 A JP 2014509823A JP 2014509823 A JP2014509823 A JP 2014509823A JP 2014516027 A5 JP2014516027 A5 JP 2014516027A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- modification
- inhibitor
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161484091P | 2011-05-09 | 2011-05-09 | |
| US61/484,091 | 2011-05-09 | ||
| US201261605376P | 2012-03-01 | 2012-03-01 | |
| US61/605,376 | 2012-03-01 | ||
| PCT/GB2012/051018 WO2012153135A1 (en) | 2011-05-09 | 2012-05-09 | Methods of modulating micrornas in the treatment of pulmonary arterial hypertension |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014516027A JP2014516027A (ja) | 2014-07-07 |
| JP2014516027A5 true JP2014516027A5 (enExample) | 2015-06-11 |
| JP6049700B2 JP6049700B2 (ja) | 2016-12-21 |
Family
ID=46178572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014509823A Expired - Fee Related JP6049700B2 (ja) | 2011-05-09 | 2012-05-09 | 肺動脈高血圧の治療におけるｍｉｃｒｏＲＮＡの調節方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9267134B2 (enExample) |
| EP (1) | EP2707485B1 (enExample) |
| JP (1) | JP6049700B2 (enExample) |
| KR (1) | KR20140037868A (enExample) |
| CN (1) | CN103814131A (enExample) |
| AU (1) | AU2012252165A1 (enExample) |
| BR (1) | BR112013029016A2 (enExample) |
| CA (1) | CA2835568A1 (enExample) |
| CO (1) | CO6870004A2 (enExample) |
| SG (1) | SG194901A1 (enExample) |
| WO (1) | WO2012153135A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2902623A1 (en) * | 2013-03-15 | 2014-09-25 | MiRagen Therapeutics, Inc. | Locked nucleic acid inhibitor of mir-145 and uses thereof |
| MX364814B (es) | 2013-03-15 | 2019-05-08 | Miragen Therapeutics Inc | Nucleosidos biciclicos unidos en puente. |
| JP2016540049A (ja) * | 2013-12-02 | 2016-12-22 | ザ ユニバーシティー コート オブ ザ ユニバーシティー オブ グラスゴー | 肺動脈性高血圧症の治療のための材料及び方法 |
| CN106794233B (zh) * | 2014-08-01 | 2021-11-12 | 布里格姆及妇女医院股份有限公司 | 与肺动脉高压的治疗有关的组合物和方法 |
| AU2016207046B2 (en) | 2015-01-13 | 2021-04-01 | Vivus Llc | Combination therapy for pulmonary hypertension |
| JP6842779B2 (ja) * | 2016-10-31 | 2021-03-17 | 国立大学法人岐阜大学 | 二本鎖核酸分子、およびその用途 |
| CA3164050A1 (en) * | 2019-12-09 | 2021-06-17 | Empirico Inc. | Oligonucleotides for treatment of angiopoietin like 4 (angptl4) related diseases |
| US20240301407A1 (en) * | 2021-01-18 | 2024-09-12 | Regen Innopharm Inc. | Composition comprising mir 145 inhibitor as active ingredient for treatment of myocardial infarction |
| WO2022183105A1 (en) * | 2021-02-26 | 2022-09-01 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treating pulmonary arterial hypertension (pah) and other disorders |
| CN113332306A (zh) * | 2021-04-28 | 2021-09-03 | 武汉华纪元生物技术开发有限公司 | 用于治疗肺动脉高血压的microRNA-30a抑制剂及其应用 |
| GB202215974D0 (en) * | 2022-10-28 | 2022-12-14 | Imperial College Innovations Ltd | Microrna panels for pulmonary hypertension |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6060451A (en) | 1990-06-15 | 2000-05-09 | The National Research Council Of Canada | Thrombin inhibitors based on the amino acid sequence of hirudin |
| WO1995003843A1 (en) | 1993-07-30 | 1995-02-09 | The Regents Of The University Of California | Endocardial infusion catheter |
| GB9525620D0 (en) | 1995-12-15 | 1996-02-14 | Glaxo Group Ltd | Chemical compounds |
| SE9600216D0 (sv) | 1996-01-18 | 1996-01-18 | Hans Arne Hansson | Styrning av läkningsprocesser |
| AU3049497A (en) | 1996-05-31 | 1998-01-05 | C & C Research Laboratories | Aromatic amidine derivatives useful as selective thrombin inhibitors |
| US5985833A (en) | 1996-09-17 | 1999-11-16 | Wisconsin Alumni Research Foundation | Thrombin inhibitor |
| US6416510B1 (en) | 1997-03-13 | 2002-07-09 | Biocardia, Inc. | Drug delivery catheters that attach to tissue and methods for their use |
| US6147109A (en) | 1997-10-14 | 2000-11-14 | The General Hospital Corporation | Upregulation of Type III endothelial cell Nitric Oxide Synthase by HMG-CoA reductase inhibitors |
| US6749617B1 (en) | 1997-11-04 | 2004-06-15 | Scimed Life Systems, Inc. | Catheter and implants for the delivery of therapeutic agents to tissues |
| SK17432000A3 (sk) | 1998-05-26 | 2001-07-10 | Icn Pharmaceuticals, Inc. | Zlúčenina, ktorá zahŕňa nukleozid s 2',4'-mostíkom a oligonukleotid z nej odvodený |
| CA2345641A1 (en) | 1998-09-28 | 2000-04-06 | Merck & Co., Inc. | A method for treating inflammatory diseases by administering a thrombin inhibitor |
| US6838283B2 (en) | 1998-09-29 | 2005-01-04 | Isis Pharmaceuticals Inc. | Antisense modulation of survivin expression |
| US6693187B1 (en) | 2000-10-17 | 2004-02-17 | Lievre Cornu Llc | Phosphinoamidite carboxlates and analogs thereof in the synthesis of oligonucleotides having reduced internucleotide charge |
| WO2005013901A2 (en) * | 2003-07-31 | 2005-02-17 | Isis Pharmaceuticals, Inc. | Oligomeric compounds and compositions for use in modulation of small non-coding rnas |
| US7722596B2 (en) | 2004-02-26 | 2010-05-25 | Osprey Medical, Inc. | Regional cardiac tissue treatment |
| CA2557480A1 (en) | 2004-02-26 | 2005-09-09 | V-Kardia Pty Ltd | Isolating cardiac circulation |
| US20070203445A1 (en) | 2004-02-26 | 2007-08-30 | V-Kardia Pty Ltd | Isolating cardiac circulation |
| WO2006089340A2 (en) | 2005-02-23 | 2006-08-31 | V-Kardia Pty Ltd | Polynucleotide delivery to cardiac tissue |
| CA2634046A1 (en) * | 2005-12-12 | 2007-06-21 | The University Of North Carolina At Chapel Hill | Micrornas that regulate muscle cell proliferation and differentiation |
| EP2279267A4 (en) * | 2008-03-27 | 2012-01-18 | Vascular Biosciences Inc | METHOD FOR IDENTIFYING NEW THERAPY CANDIDATES ON GENE EXPRESSION ANALYSIS IN DISEASES RELATED TO VACCINES |
| US8735568B2 (en) * | 2009-03-09 | 2014-05-27 | The J. David Gladstone Institutes | Methods of modulating smooth muscle cell proliferation and differentiation |
| CN101843632B (zh) * | 2009-03-24 | 2012-07-04 | 复旦大学附属华山医院 | miR-145在制备治疗炎症药物中的应用 |
| MA33488B1 (fr) * | 2009-06-08 | 2012-08-01 | Miragen Therapeutics | Motifs de modification chimique pour des inhibiteurs et mimétiques de miarn |
| RU2012129900A (ru) * | 2009-12-15 | 2014-01-27 | Борд Оф Риджентс, Дзе Юниверсити Оф Техас Систем | Регуляция микро-рнк при ишемии и ишемически-реперфузионном повреждении |
| CN102382824A (zh) * | 2010-09-01 | 2012-03-21 | 中国科学院上海药物研究所 | 人miR-145反义核酸及其应用 |
-
2012
- 2012-05-09 WO PCT/GB2012/051018 patent/WO2012153135A1/en not_active Ceased
- 2012-05-09 AU AU2012252165A patent/AU2012252165A1/en not_active Abandoned
- 2012-05-09 JP JP2014509823A patent/JP6049700B2/ja not_active Expired - Fee Related
- 2012-05-09 CN CN201280034183.8A patent/CN103814131A/zh active Pending
- 2012-05-09 KR KR1020137032530A patent/KR20140037868A/ko not_active Withdrawn
- 2012-05-09 CA CA2835568A patent/CA2835568A1/en not_active Abandoned
- 2012-05-09 SG SG2013083480A patent/SG194901A1/en unknown
- 2012-05-09 EP EP12724369.9A patent/EP2707485B1/en not_active Not-in-force
- 2012-05-09 BR BR112013029016A patent/BR112013029016A2/pt not_active IP Right Cessation
- 2012-05-09 US US14/116,724 patent/US9267134B2/en not_active Expired - Fee Related
-
2013
- 2013-11-14 CO CO13268130A patent/CO6870004A2/es not_active Application Discontinuation